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The ability of the isolated carboxy-terminal domain of the LexA repressor of Escherichiu coli to form dimers and 
tetramers has been investigated by equilibrium ultracentrifugation. This domain, that comprises the amino acids 85-202, 
is readily purified after self-cleavage of the LexA repressor at alkaline pH. It turns out that the carboxy-terminal domain 
forms dimers and tetramers essentially as the entire LexA repressor. The corresponding association constants were de- 
termined after non-linear least squares fitting of the experimental concentration distribution. A dimer association con- 
stant of Kz = 3 x 104 M-r and a tetramer association constant of K, = 2 x 104 M-r have been determined. Similar mea- 
surements on the entire LexA repressor [(1985) Biochemistry 24, 2812-28181 gave values of Kz = 2.1 x lo4 M-r and 
& = 7.7 x 104 M-r. Within experimental error the dimer formation constant of the carboxy-terminal domain may be 
considered to be the same as that of the entire repressor whereas the isolated domain forms tetramers slightly less efficient- 
ly. It should be stressed that the potential error in K4 is higher than that in K2. The overall conclusion is that the two 
structural domains of LexA have also well-defined functional roles: the amino-terminal domain interacts with DNA and 
the carboxy-terminal domain is involved in dimerisation reinforcing in this way the binding of the LexA repressor to 
operator DNA. 
SOS system; LexA repressor; RecA protein; DNA-binding protein; Multi-domain protein; Equilibrium ultracentrifugation 
1. INTRODUCTION 
The LexA repressor of Escherichia coli differs 
from other repressors in that it controls the expres- 
sion of a whole set of unlinked genes involved in 
very different cellular functions like DNA repair, 
mutagenesis, cell division as well as a set of 
bacterial toxins and its own gene (for a review see 
[l]). This regulatory network, the well known 
‘SOS-system’, raises the question how a single 
repressor may achieve a satisfying regulation of 
gene products needed at very different basal and 
constitutive levels. 
It turns out that LexA acts as a fairly weak 
repressor in the case of the excision repair genes 
uvrA and uvrB (for a comparison of the strength 
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of the different SOS operators see [2]) and as a 
‘medium strength’ repressor in the case of the 
genes involved in mutagenesis for example. These 
differences in LexA affinity are apparently, 
mediated by slight variations within the central 
part of the different SOS operators. 
The overall weakness of the LexA repressor with 
respect to other repressors is probably linked to its 
low dimerisation constant of only 2.1 x lo4 M-i 
[3]. This view is supported by our finding that the 
isolated amino-terminal DNA binding domain of 
LexA (the first 84 amino acids out of a total of 
202) retains substantial DNA binding affinity 
12,431. 
Here we show by equilibrium ultracentrifuga- 
tion measurements that the isolated C-terminal do- 
main (amino acids 85-202) shows a very similar 
dimerisation and tetramerisation behaviour to the 
entire repressor. This finding supports the view of 
a structural and functional dissection of the LexA 
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repressor into an amino-terminal DNA binding 
and a carboxy-terminal dimerising domain. 
2. MATERIALS AND METHODS 
2. I. Prolein purification 
The LexA repressor has been purified as described earlier [3]. 
After self-cleavage of LexA at pH 9 for 4 h the two resulting 
domains have been purified as described [4]. The concentration 
of the carboxy-terminal domain was determined using an ex- 
tinction coefficient at 280 nm of 7300 M-t .cm-’ as for the en- 
tire repressor [6]. 
2.2. Equilibrium sedimentation 
The equilibrium measurements were conducted in a double- 
sector cell with a column height of 0.4 cm at 27060 rpm 
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(2217 + 1 ps) during 46 h using a Beckman analytical ultracen- 
trifuge equipped with a home-made optical scanning device [7]. 
Since the molecular weight of the monomer was known 
(13.1 kDa), a program of least squares fit was used to achieve 
the resolution of components in the concentration distribution 
at equilibrium. The value of the partial specific volume was 
taken to be 0.740 cm3.g-’ as determined from the amino acid 
sequence of the carboxy-terminal domain of the LexA 
repressor. The measurements were made at 7°C under the same 
experimental conditions as those used for the entire LexA 
repressor, that is 10 mM sodium phosphate, pH 7.2, 150 mM 
NaCl and 0.1 mM EDTA. 
3. RESULTS AND DISCUSSION 
Fig. 1 shows the distribution of protein along the 
)_ 
r 
4 
48.0 51.0 f-x cm’ 
2.0 
I.6 
1.0 
as 
ao 
0.7 
0.6 
0.6 
0.4 
0.3 
0.26 
0.2 
0. I6 
0.1 
0.06 
Fig.]. Self-association of the carboxy-terminal domain of LexA plotted as In A~.z-xw, vs 2. Thl measurements were done at 
27060 rpm, T = 281 K. Initial loading concentrations were (+) 0.408 mg/ml (cell I), (0) 0.684 mg/ml (cell 2), (x) 1.03 mg/ml (cell 
3). The solid curves through the experimental points are the total concentration distributions calculated from the results of the least- 
squares fits. The straight lines are the concentration distributions of the individual components in cell 1: monomer (-a--), dimer 
(-.*-), tetramer (-***.--). 
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cell as measured from the absorption A at 280 nm 
as a function of the distance r from the rotor axis. 
The precision of successive readings within the 
same cell is fairly high with errors not exceeding 
the size of the symbols used in the figures. Such 
InA versus ? plots are linear for monodisperse 
systems. In the case of the carboxy-terminal do- 
main of LexA these plots are curved showing that 
the system undergoes oligomerisation. 
one. A useful way to answer this question is the so- 
called ‘two-species plot’ [8], which consists of a 
plot of respectively A& vs l/M, or M, vs l/M,. 
For a definition of the different average molecular 
weights see the legend of fig.2. 
It is not immediately obvious from such a 
distribution which are the limiting species of 
oligomerisation, that is the smallest and the biggest 
The two-species plot (fig.2) shows that all the 
data points are comprised within the triangle de- 
fined by the monomer, the dimer and the tetramer 
as was the case for the entire LexA repressor [3]. 
This finding suggests that the smallest species is the 
monomer and the biggest one the tetramer. In con- 
trary to phage lambda repressor [9], LexA and its 
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Fig.2. Two-species plot for the carboxy-terminal domain of LexA as determined from the equilibrium experiment shown in fig.1. (e) 
MW versus l/M”; (A) M, versus l/M,. The solid curve is drawn with the values of the average molecular weight calculated from the 
least squares fit. The different average molecular weights are defined as follows: M, = C Cj/(C Cj/Mj); Mw = C CjMj/C Cj; hf, = 
c CjMT/(C CjMj). The hyperbola corresponds to &(1/M-j) = 1. 
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carboxy-terminal domain apparently do not form 
higher molecular weight aggregates. 
Using the monomer and the tetramer as limiting 
species we have fitted the experimental protein 
distribution in the three measuring cells (fig.1) by 
a sum of exponentials using a least-squares fitting 
procedure (for details of this procedure see [3]). As 
in the case of LexA the existence of a trimer is not 
compatible with the experimental data, since if it is 
included into the fitting procedure its concentra- 
tion always turns out to be negative. The system 
may thus be described by two coupled equilibria: 
a monomer-dimer and a subsequent dimer- 
tetramer equilibrium. Once the observed protein 
distribution has been decomposed into its three 
components (monomer, dimer, tetramer) the 
dimer formation constant KZ and the tetramer for- 
mation constant K4 may be determined from the 
following equation [3]: 
(C-r - Cr)/C: = 2Kz + 4K: - K4. c: 
where Cr and Cr are respectively the free monomer 
and the total protein concentration. From a plot of 
(Cr - Cr)/G vs C? the equilibrium constants KZ 
and K4 are readily obtained. 
This procedure gives slightly different results of 
Kz and K4 from one measuring cell to the other. 
The calculated average association constants for 
the three different loading concentrations are K2 = 
3 x lo4 M- ’ ( + 20%) for dimer formation and 
K4 = 2 x lo4 M-’ (t 50%) for tetramer for- 
mation. 
Within experimental error we find thus the same 
dimerisation constant for the carboxy-terminal do- 
main as that determined earlier for LexA, that is 
2.1 x lo4 M-’ [3]. The tetramerisation constant of 
the carboxy-terminal domain appears somewhat 
smaller than that of the entire repressor (K4 = 2 x 
lo4 M-’ instead of 7.7 x lo4 M-l). Taking into 
account the rather high error for this constant (er- 
rors in KZ are propagated to K4) the difference be- 
tween the two protein species in tetramerisation 
appears not very significant. 
We may thus argue that the isolated carboxy- 
terminal domain of LexA forms dimers and 
tetramers essentially with the same binding con- 
stants as the entire protein. 
This finding immediately suggests that essential- 
ly no dimerisation energy should arise from in- 
teractions between the amino-terminal domains of 
LexA. Unfortunately this domain harbors neither 
tyrosine nor tryptophan residues and is thus not 
suitable for measurements with our optical scann- 
ing ultracentrifuge. There is nevertheless indirect 
evidence from NMR measurements at high concen- 
trations of amino-terminal domain (about 6 mM) 
that this domain has no pronounced tendency to 
aggregate, because well-resolved two-dimensional 
data sets could be collected (our unpublished 
results). This is apparently not possible in the case 
of the isolated DNA binding domain of the phage 
lambda repressor [lo] that has been shown to 
dimerise with an association constant of about 3 x 
lo3 M-’ [ll]. 
The LexA repressor and the phage lambda 
repressor share significant homology within their 
carboxy-terminal domains [ 121. This homology 
may be functionally linked to the dimerisation of 
each of these domains and/or to the fact that both 
domains probably contain the catalytic center for 
the (self-) cleavage reaction. In the case of LexA 
the amino acids serine-119 and lysine-156 seem to 
be crucially involved in this cleavage reaction [ 131. 
Despite this partial homology of the two repressor 
species the dimerisation of LexA occurs with an 
about 3000-fold smaller association constant (2.1 
x lo4 M-’ instead of 5.9 x 10’ M-’ [14] in the 
case of the phage lambda repressor). This dif- 
ference in dimerisation probably accounts for the 
finding that the self-cleavage reaction of phage 
lambda repressor is strongly inhibited by increas- 
ing repressor concentration, whereas the self- 
cleavage of LexA shows no concentration 
dependence in the range from 10m9 to 10e5 M [15]. 
We may estimate that at lo-’ M of LexA always 
about 75% of the protein should be in the 
monomeric state [3] and it is thus not surprising 
that no concentration dependence of the cleavage 
reaction has been observed. If the LexA dimer is 
unable to undergo self-cleavage, as seems to be the 
case for the phage lambda repressor, a concentra- 
tion dependent inhibition would be expected to oc- 
cur in the range from 10m5 to 10m3 M of LexA. 
Fig.3 shows the distribution of each species as a 
function of the concentration of the carboxy- 
terminal domain. Up to 0.35 mg/ml, the monomer 
is the dominating species. Using a molecular mass 
of 13.1 kDa this corresponds to a concentration of 
27 PM, which is far above the concentration ex- 
pected to occur in vivo. 
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Fig.3. Plot of the fractions of monomer, dimer and tetramer of 
the carboxy-terminal domain of LexA vs the total 
concentration. The values of the equilibrium constants are 
respectively Kz = 3 x IO4 M-’ and Kd = 2 x IO4 Me’. 
4. CONCLUSION 
The specific self-cleavage reaction of LexA 
allows one to isolate two unique structural and 
functional domains without loss of smaller peptide 
fragments in between. Such a favorable situation is 
normally not encountered if structural domains are 
isolated following cleavage with proteolytic en- 
zymes. The two structural domains have apparent- 
ly also well-defined functional roles: the 
amino-terminal domain interacts with DNA, and 
the carboxy-terminal domain is mainly involved in 
dimerisation reinforcing in this way the binding of 
the entire LexA repressor to operator DNA. The 
oligomerisation data reported here constitute so 
far the only measurable ‘activity’ of the isolated 
carboxy-terminal domain and provide indirect 
evidence that the domain does not undergo un- 
folding or a major structural reorganisation upon 
cleavage. 
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